AR054256A1 - Suplemento nutricional para una categoria de pacientes con hiv - Google Patents
Suplemento nutricional para una categoria de pacientes con hivInfo
- Publication number
- AR054256A1 AR054256A1 AR20060101604A ARP060101604A AR054256A1 AR 054256 A1 AR054256 A1 AR 054256A1 AR 20060101604 A AR20060101604 A AR 20060101604A AR P060101604 A ARP060101604 A AR P060101604A AR 054256 A1 AR054256 A1 AR 054256A1
- Authority
- AR
- Argentina
- Prior art keywords
- hiv
- oligosaccharides
- patients
- nutritional
- nutritional supplement
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Un producto nutricional para pacientes con HIV que no están sometidos a una Terapia Antirretroviral Altamente Activa. En forma más específica la presente se relaciona con una composicion nutricional que comprende oligosacáridos. También se describe la elaboracion de un suplemento nutricional para usar en pacientes con HIV. Reivindicacion 1: Uso de uno o más oligosacáridos, caracterizado porque dichos oligosacáridos se eligen entre: oligosacáridos ácidos preparados a partir de pectina, pectato, alginato, condroitina, ácidos hialuronicos, heparina, heparano, carbohidratos bacterianos, sialoglicanos, fucoidano, fucooligosacáridos o carragenano u oligosacáridos neutros seleccionados de grupo que consiste en galactooligosacáridos, fructooligosacáridos, transgalactooligosacáridos xilooligo-sacáridos, lactosacarosa y arabinooligosacáridos en la elaboracion de una composicion para usar en un método para el tratamiento y/o la prevencion del HIV en un sujeto humano que tiene un recuento de linfocitos CD4+ T entre 200 y 700 células/microlitro de sangre y donde dicho sujeto no está tratado con Terapia Antirretroviral Altamente Activa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05103260A EP1721611A1 (en) | 2005-04-21 | 2005-04-21 | Nutritional supplement with oligosaccharides for a category of HIV patients |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054256A1 true AR054256A1 (es) | 2007-06-13 |
Family
ID=34939443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR20060101604A AR054256A1 (es) | 2005-04-21 | 2006-04-21 | Suplemento nutricional para una categoria de pacientes con hiv |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090082249A1 (es) |
EP (2) | EP1721611A1 (es) |
JP (1) | JP2008536915A (es) |
CN (1) | CN101262783A (es) |
AR (1) | AR054256A1 (es) |
AU (1) | AU2006237739A1 (es) |
BR (1) | BRPI0610784A2 (es) |
CA (1) | CA2605210A1 (es) |
MX (1) | MX2007013082A (es) |
NO (1) | NO20075323L (es) |
NZ (1) | NZ562666A (es) |
RU (1) | RU2007143060A (es) |
WO (1) | WO2006112717A2 (es) |
ZA (1) | ZA200709047B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
WO2004019699A1 (en) * | 2002-08-30 | 2004-03-11 | Campina B.V. | Foaming ingredient and products containing the ingredient |
EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
RU2429718C2 (ru) * | 2004-06-22 | 2011-09-27 | Н.В. Нютрисиа | Повышение целостности барьера у больных с вич |
EP1723951A1 (en) * | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
US20080171720A1 (en) * | 2005-04-21 | 2008-07-17 | N.V. Nutricia | Nutritional Supplement For Hiv Patients |
WO2008156354A1 (en) * | 2007-06-21 | 2008-12-24 | N.V. Nutricia | Modulation of intestinal flora of hiv patients |
WO2009096772A1 (en) * | 2008-02-01 | 2009-08-06 | N.V. Nutricia | Composition for stimulating natural killer cell activity |
SG191799A1 (en) | 2010-12-31 | 2013-08-30 | Abbott Lab | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof |
US8802650B2 (en) | 2010-12-31 | 2014-08-12 | Abbott Laboratories | Methods of using human milk oligosaccharides for improving airway respiratory health |
US9795623B2 (en) | 2010-12-31 | 2017-10-24 | Abbott Laboratories | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin C and anti-inflammatory agents |
SG10202110501RA (en) | 2010-12-31 | 2021-11-29 | Abbott Lab | Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides |
BR112013015951A2 (pt) | 2010-12-31 | 2018-07-10 | Abbott Lab | composições nutricionais compreendendo oligossacarídeos e nucleotídeos de leite humano e usos destas para tratar e/ou prevenir infecção viral entérica. |
SG191393A1 (en) | 2010-12-31 | 2013-08-30 | Abbott Lab | Neutral human milk oligosaccharides to promote growth of beneficial bacteria |
MY165628A (en) | 2010-12-31 | 2018-04-18 | Abbott Lab | Human milk oligosaccharides for modulating inflammation |
WO2012177118A1 (en) * | 2011-06-22 | 2012-12-27 | N.V. Nutricia | Method for reducing the occurrence of infection in young children |
CN107595860A (zh) | 2011-07-22 | 2018-01-19 | 雅培制药有限公司 | 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖 |
SG2014013478A (en) | 2011-08-29 | 2014-05-29 | Abbott Lab | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
WO2015148384A1 (en) | 2014-03-26 | 2015-10-01 | Abbott Laboratories | Nutritional supplement powder |
WO2017151540A1 (en) | 2016-02-29 | 2017-09-08 | Abbott Laboratories | Nutritional supplement powder |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2981629A (en) * | 1960-04-05 | 1961-04-25 | Lewis F Ginnette | Process of dehydrating foams |
US4237118A (en) * | 1972-03-06 | 1980-12-02 | Howard Alan N | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
JPS5645951B2 (es) * | 1973-05-21 | 1981-10-29 | ||
FR2490496A1 (fr) * | 1980-09-19 | 1982-03-26 | Roussel Uclaf | Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant |
US4438147A (en) * | 1982-06-25 | 1984-03-20 | Societe D'assistance Technique Pour Produits Nestle S.A. | Foaming creamer and method of making same |
DE3734962C1 (de) * | 1987-10-15 | 1989-01-05 | Luitpold Werk Chem Pharm | Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC |
JPH01149730A (ja) * | 1987-12-07 | 1989-06-12 | Osaka Prefecture | レトロウイルス増殖抑制剤 |
DE68904264T2 (de) * | 1988-08-24 | 1993-05-27 | Akzo Nv | Fragmente und fraktionen von heparin mit wirkung gegen hiv. |
JP2782443B2 (ja) * | 1988-12-26 | 1998-07-30 | 將純 吉原 | 抗エイズウィルス剤 |
ES2033193B1 (es) * | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
ZA92452B (en) * | 1991-01-24 | 1992-10-28 | Martek Corp | Microbial oil mixtures and uses thereof |
FR2673812B1 (fr) * | 1991-03-13 | 1994-04-01 | Roussel Uclaf | Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications. |
JPH04300888A (ja) * | 1991-03-28 | 1992-10-23 | Dainippon Ink & Chem Inc | カルボン酸オリゴ糖エステル硫酸化物 |
IT1248060B (it) * | 1991-06-14 | 1995-01-05 | Italfarmaco Spa | Eparine acilate come inibitori della replicazione di retrovirus |
US5629023A (en) * | 1991-12-31 | 1997-05-13 | Bland; Jeffrey S. | Medical food composition for metabolic detoxification |
US5502041A (en) * | 1992-12-11 | 1996-03-26 | The Center For Innovative Technology | Potent inhibitor of HIV reverse transcriptase |
US5472952A (en) * | 1993-03-18 | 1995-12-05 | Bristol-Myers Squibb Company | Partially hydrolyzed pectin in nutritional compositions |
JP3310738B2 (ja) * | 1993-11-10 | 2002-08-05 | 株式会社ロッテ | 低カロリーチョコレート |
DE4404877C1 (de) * | 1994-02-17 | 1995-03-02 | Ksk Industrielackierungen Gmbh | Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung |
US5444054A (en) * | 1994-04-01 | 1995-08-22 | Abbott Labatories | Method of treating ulcerative colitis |
US5952314A (en) * | 1994-04-01 | 1999-09-14 | Demichele; Stephen Joseph | Nutritional product for a person having ulcerative colitis |
US5531989A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
US5531988A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Bacteria and immunoglobulin-containing composition for human gastrointestinal health |
JPH08151328A (ja) * | 1994-11-28 | 1996-06-11 | Fuji Ratetsukusu Kk | エイズ感染防止潤滑剤 |
US5733579A (en) * | 1995-04-05 | 1998-03-31 | Abbott Laboratories | Oral rehydration solution containing indigestible oligosaccharides |
US20020016289A1 (en) * | 1995-06-01 | 2002-02-07 | Orla M. Conneely | Methods for treatment and prevention of helicobacter pylori infection using lactoferrin |
US5827526A (en) * | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
DE69506095T2 (de) * | 1995-08-04 | 1999-06-24 | Nutricia Nv | Diätfasern enthaltende Nahrungszusammensetzung |
MY115050A (en) * | 1995-10-16 | 2003-03-31 | Mead Johnson Nutrition Co | Diabetic nutritional product having controlled absorption of carbohydrate |
JPH10108647A (ja) * | 1996-10-08 | 1998-04-28 | Meiji Seika Kaisha Ltd | 胃切除術後患者用ミネラル補給材 |
JP4008974B2 (ja) * | 1996-12-12 | 2007-11-14 | 森永乳業株式会社 | ビフィズス菌増殖促進組成物及びその用途 |
DE19701382A1 (de) * | 1997-01-16 | 1998-07-23 | Nutricia Nv | Kohlenhydratmischung |
ATE265207T1 (de) * | 1997-02-21 | 2004-05-15 | Abbott Lab | Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis |
US5840361A (en) * | 1997-04-09 | 1998-11-24 | Beech-Nut Nutrition Corporation | Fructan-containing baby food compositions and methods therefor |
NL1005809C2 (nl) * | 1997-04-14 | 1998-10-19 | Dsm Nv | Poederverfbindmiddelsamenstelling. |
US5846569A (en) * | 1997-06-20 | 1998-12-08 | Creative Labs, Inc. | Colostrum supplement |
US6051260A (en) * | 1998-04-07 | 2000-04-18 | Healthcomm International, Inc. | Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity |
FR2781673B1 (fr) * | 1998-07-28 | 2001-09-28 | Univ Picardie | Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation |
DE19836339B4 (de) * | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
US6231889B1 (en) * | 1998-09-21 | 2001-05-15 | Chronorx, Llc | Unit dosage forms for the treatment of herpes simplex |
US6794495B1 (en) * | 1998-10-19 | 2004-09-21 | New Nordic Danmark Aps | Composition comprising extensin and, optionally, pectic polysaccharides |
AU765510B2 (en) * | 1999-01-28 | 2003-09-18 | Societe Des Produits Nestle S.A. | Aromatised soluble creamer powder |
EP1074181A1 (en) * | 1999-08-03 | 2001-02-07 | Societe Des Produits Nestle S.A. | Foaming creamer ingredient and powders containing it |
DE19940011B4 (de) * | 1999-08-24 | 2009-04-02 | Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte | Alginataufbereitung und deren Verwendung |
US6737089B2 (en) * | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
DE10006989A1 (de) * | 2000-02-16 | 2001-08-23 | Nutricia Nv | Antiadhäsive Kohlenhydratmischung |
US6846501B2 (en) * | 2000-04-12 | 2005-01-25 | Mid-America Commercialization Corporation | Traditional snacks having balanced nutritional profiles |
DE10027050A1 (de) * | 2000-06-02 | 2001-12-13 | Karim Balan | Alginathaltige Zusammensetzung und deren Verwendung |
US6426110B1 (en) * | 2000-08-11 | 2002-07-30 | Global Health Sciences, Inc. | Low-carbohydrate high-protein creamer powder |
US6592863B2 (en) * | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
CN1111541C (zh) * | 2000-09-15 | 2003-06-18 | 青岛海洋大学 | 一种聚甘露糖醛酸硫酸盐 |
DE10057976B4 (de) * | 2000-11-22 | 2005-02-03 | Südzucker AG Mannheim/Ochsenfurt | Verfahren zur Herstellung von Pektinhydrolyseprodukten |
US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
WO2002064714A1 (fr) * | 2001-02-15 | 2002-08-22 | Asahi Denka Kogyo Kabushiki Kaisha | Produits contenant du $g(b)-glucane |
AU2003245252A1 (en) * | 2002-04-30 | 2003-11-17 | Fmc Corporation | Carrageenan based antimicrobial compositions |
WO2004019699A1 (en) * | 2002-08-30 | 2004-03-11 | Campina B.V. | Foaming ingredient and products containing the ingredient |
US20040122105A1 (en) * | 2002-09-20 | 2004-06-24 | Griscom Bettle | Transdermal compositions |
US6974841B1 (en) * | 2002-09-27 | 2005-12-13 | Rapisarda Family Irrevocable Trust | Pet anti-aging wellness supplement |
US20040219188A1 (en) * | 2003-05-02 | 2004-11-04 | Comer Gail M. | Composition and methods for nutritional management of patients with hepatic disease |
AU2003904192A0 (en) * | 2003-08-11 | 2003-08-21 | Adelaide Research and Innovaiton Pty Ltd | Method for inhibiting bacterial colonisation |
RU2388478C2 (ru) * | 2003-10-24 | 2010-05-10 | Н.В. Нютрисиа | Иммуномодулирующие олигосахариды |
FR2866203B1 (fr) * | 2004-02-13 | 2006-12-08 | Roquette Freres | Procede de fabrication d'un produit de cuisson a base de gluten |
EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) * | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
EP1723951A1 (en) * | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
RU2429718C2 (ru) * | 2004-06-22 | 2011-09-27 | Н.В. Нютрисиа | Повышение целостности барьера у больных с вич |
EP1778857A4 (en) * | 2004-07-07 | 2007-09-26 | Gen Hospital Corp | DIRECT ACTIVATION OF ATIII IN FULL BLOOD AND PLASMA |
EP1919300A1 (en) * | 2005-07-27 | 2008-05-14 | Cantabria Group LCC | Phosphorytated glucomannan polysaccharides containing 1-6 and 1-2 linkages increase weight gain in swine |
-
2005
- 2005-04-21 EP EP05103260A patent/EP1721611A1/en not_active Withdrawn
-
2006
- 2006-04-19 BR BRPI0610784-2A patent/BRPI0610784A2/pt not_active Application Discontinuation
- 2006-04-19 CA CA002605210A patent/CA2605210A1/en not_active Abandoned
- 2006-04-19 AU AU2006237739A patent/AU2006237739A1/en not_active Abandoned
- 2006-04-19 WO PCT/NL2006/050092 patent/WO2006112717A2/en active Application Filing
- 2006-04-19 JP JP2008507580A patent/JP2008536915A/ja not_active Withdrawn
- 2006-04-19 EP EP06733071A patent/EP1874136A2/en not_active Withdrawn
- 2006-04-19 RU RU2007143060/13A patent/RU2007143060A/ru not_active Application Discontinuation
- 2006-04-19 NZ NZ562666A patent/NZ562666A/en not_active IP Right Cessation
- 2006-04-19 US US11/912,093 patent/US20090082249A1/en not_active Abandoned
- 2006-04-19 CN CNA2006800210770A patent/CN101262783A/zh active Pending
- 2006-04-19 MX MX2007013082A patent/MX2007013082A/es not_active Application Discontinuation
- 2006-04-21 AR AR20060101604A patent/AR054256A1/es unknown
-
2007
- 2007-10-17 NO NO20075323A patent/NO20075323L/no not_active Application Discontinuation
- 2007-10-19 ZA ZA200709047A patent/ZA200709047B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20075323L (no) | 2008-01-21 |
US20090082249A1 (en) | 2009-03-26 |
MX2007013082A (es) | 2008-01-11 |
WO2006112717A2 (en) | 2006-10-26 |
CA2605210A1 (en) | 2006-10-26 |
EP1721611A1 (en) | 2006-11-15 |
RU2007143060A (ru) | 2009-06-10 |
JP2008536915A (ja) | 2008-09-11 |
NZ562666A (en) | 2011-03-31 |
ZA200709047B (en) | 2008-09-25 |
WO2006112717A3 (en) | 2007-07-12 |
BRPI0610784A2 (pt) | 2010-11-09 |
CN101262783A (zh) | 2008-09-10 |
AU2006237739A1 (en) | 2006-10-26 |
EP1874136A2 (en) | 2008-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR054256A1 (es) | Suplemento nutricional para una categoria de pacientes con hiv | |
AR054257A1 (es) | Suplemento nutricional para pacientes con hiv | |
AR077520A1 (es) | Uso de esfingomielina y carbohidratos no digeribles para mejorar la microbiota intestinal | |
EP1871181B2 (en) | Nutritional supplement for hiv patients | |
CA2570208A1 (en) | Improvement of barrier integrity in hiv patients | |
ES2667033T3 (es) | Viscosidad extensional para favorecer una deglución segura de los bolos de alimentos | |
RU2013135311A (ru) | Комбинация компонентов для профилактики и лечения немощности | |
EP2123282A3 (en) | Immunemodulating oligosaccharides | |
NZ599748A (en) | Improving memory in subjects with mini-mental state examination of 24-26 | |
CN101248873A (zh) | 具有视力保护功能的饮用食品 | |
BRPI0509017A (pt) | composições hmb e utilizações das mesmas | |
RU2002130724A (ru) | Питательные модули | |
WO2014070016A3 (en) | Synbiotics combination for brain improvement | |
RU2007102085A (ru) | Улучшение целостности интестинального барьера | |
AU2014290766B2 (en) | Methods for promoting neuronal development and/or health | |
JP2010531351A5 (es) | ||
WO2015156942A1 (en) | Methods of use for probiotics and prebiotics | |
CN112385827A (zh) | 高能量密度酪蛋白型全营养特医食品乳剂及其制备方法 | |
WO2016053563A1 (en) | Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile | |
US9226914B2 (en) | Methods for promoting neuronal development and/or health | |
ATE424732T1 (de) | Zubereitungen enthaltend mehrfach ungesättigte phospholipide, monoterpene und tryptophan und/oder phytol-derivate | |
EP3426236B1 (en) | Method for supporting memory function and/or cognitive function | |
WO2008045528A3 (en) | Methods and compositions for the treatment of cancer | |
JP2008301780A (ja) | アトピー性皮膚炎改善用食品 | |
Diel et al. | Performance Enhancing And Pro Regenerative Effects Of Alpha Lipoic Acid Supplementation After Acute And Chronic Resistance And Endurance Training. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |